feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Science / Alzheimer's Reversed in Mice: Cellular Energy Key

Alzheimer's Reversed in Mice: Cellular Energy Key

11 Jan

•

Summary

  • Cellular energy molecule NAD+ deficiency linked to Alzheimer's onset.
  • Restoring NAD+ levels reversed advanced Alzheimer's in mice.
  • Cognitive function and tau markers improved in treated mice.
Alzheimer's Reversed in Mice: Cellular Energy Key

Alzheimer's disease, long considered irreversible, may now have a potential pathway to reversal. Recent research has identified a critical role for the cellular energy molecule NAD+ in brain health. Studies indicate that a deficiency in NAD+ is a major factor in the development of Alzheimer's disease.

Scientists successfully replenished NAD+ levels in mice exhibiting advanced stages of Alzheimer's. This intervention led to a reversal of the disease and a restoration of cognitive abilities. The findings suggest a novel therapeutic approach targeting cellular energy metabolism.

Further analysis revealed that the treated mice also exhibited normalized blood levels of phosphorylated tau 217. This protein abnormality is increasingly recognized as a significant biomarker for Alzheimer's disease in humans, offering hope for future treatments.

This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
trending

Daycare workers sentenced for abuse

trending

Astronauts return after health crisis

trending

49ers to play Seahawks

trending

USS Abraham Lincoln drills China

trending

Bills Broncos NFL Playoff Game

trending

Patriots await Steelers or Texans

trending

Golden Globes 2026 awards

trending

Eagles offensive coordinator fate?

trending

Chargers prepare for Patriots game

Disclaimer:
The study showed reversal in mice, suggesting a potential pathway, but human trials are needed to confirm efficacy.
NAD+ is a cellular energy molecule. Its deficiency is linked to the onset and progression of Alzheimer's disease.
Normalized blood levels of phosphorylated tau 217 were observed in treated mice, indicating potential new biomarkers.

Read more news on

Scienceside-arrow

You may also like

Most Alzheimer's Cases Linked to Single Gene

9 Jan • 16 reads

article image

World's Youngest Alzheimer's Patient Diagnosed at 19

10 Jan • 11 reads

article image

Stomach Bug Protein Fights Alzheimer's Plaque

7 Dec, 2025 • 195 reads

article image

Brain's Immune Cells: New Alzheimer's Protectors?

1 Dec, 2025 • 203 reads

Boxers' Brains Reveal Hidden Damage Pathway

1 Dec, 2025 • 210 reads